Xtant Medical Holdings Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

XTNT 1.80 +0.03 (1.69%)
price chart
Xtant Medical Holdings, Inc. to Report Second Quarter 2016 Financial Results ...
BELGRADE, Mont., July 19, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the period ...
Xtant Medical Holdings Inc (XTNT) Downgraded by Zacks Investment Research to Sell
Xtant Medical Holdings Inc (NASDAQ:XTNT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday.
Xtant Medical Holdings, Inc. to Report First Quarter 2016 Financial Results on ...
BELGRADE, Mont., April 27, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the ...
Xtant Medical Holdings Inc (XTNT) CEO Daniel S. Goldberger Acquires 5000 Shares
Xtant Medical Holdings logo Xtant Medical Holdings Inc (NASDAQ:XTNT) CEO Daniel S. Goldberger bought 5,000 shares of the stock in a transaction dated Monday, May 9th.
Xtant Medical Holdings Inc (XTNT) gets “Sell” status at Zacks Investment Research
Xtant Medical Holdings Inc (NASDAQ:XTNT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, MarketBeat reports.
Xtant Medical Holdings Inc. ($XTNT) Stock | Shares Spike Higher on FDA Approval
This morning before the market opened shares of Xtant Medical announced that they had received FDA approval for its Xspan(TM) Laminoplasty Fixation System, which is a procedure that removes pressure from the spinal cord.
Xtant Medical Holdings Announces Uplisting to NYSE MKT
BELGRADE, Mont., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its common stock has been approved for listing on the ...
Xtant Medical Holdings' (XTNT) CEO Dan Goldberger on Q4 2015 Results ...
That transaction was closed on July 31, 2015. We changed the name of the combined company to Xtant Medical Holdings Inc. and moved up to the New York Stock Exchange under the XTNT ticker soon after that.
Xtant Medical Holdings' (XTNT) CEO Daniel Goldberger on Q1 2016 Results ...
Thank you, Donna. Good morning and thank you for joining us today for the Xtant Medical Holdings, Inc. first quarter 2016 results conference call.
Xtant Medical Holdings Incorporated (NYSEMKT:XTNT) Shorts Decreased by 17.35 ...
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, makes and markets regenerative medicine products and medical devices for domestic and international markets.